John Lee joins Diagonal as CMO

Diagonal Therapeutics, a US biotech focused on correcting dysregulated signaling with clustering antibodies that address the underlying cause of intractable genetic diseases, has announced the appointment of John Lee (pictured above) as chief medical officer (CMO).

Dr Lee, who brings more than 25 years of combined experience in the pharmaceutical industry, academic medicine and clinical practice, and has led worldwide drug development strategy and execution for numerous therapeutics, will oversee Diagonal’s clinical development programs, providing strategic direction and operational leadership as the company advances its pipeline into the clinic.